Health reporter
In the UK, infants can now be preserved against a common winter virus in the UK that can cause a dangerous lung infection, and sometimes kill.
NHS Medix stated that the injection would provide them “with a protective bubble”, against the RSV (respiratory synchronous virus) for the cold months.
Most infants are protected through late vaccination in pregnancy, but children born before 32 weeks are more vulnerable to virus-drew infections.
From the end of September, 9,000 infants and young children at risk in the UK will be offered a dose of the drug Nirisavimab through NHS.
RSV usually causes cough and cold, but can make some children very sick with breathing problems, pneumonia and a lung infection called bronchioleitis.
According to NHS England, premature infants have three times the possibility of going to the hospital with RSV and requires 10 times more intensive care than the full -time infants.
Every year about 30,000 children in Britain require hospital care at the age of five due to viruses, and about 30 are not alive.
The drug provides six months of protection in a single dose, and more than 80% is effective.
The neo-nottal clinic will distribute injections to premature infants. Families of weak infants with heart or lung conditions or weak immune systems will be advised by their medical teams how to get jobs before this winter.
NHS England co-national medicine Director Dr. Claire Fuller said, “It will offer a long -lasting defense, which will help unnecessarily hospitalize and avoid serious illness, allowing infants to get the best start in life and protect them from damage.”
Last year, a vaccination program was launched in the UK To protect newborns and older people from RSV. Women who are at least 28 weeks pregnant and are now offered to people between the ages of 75 to 79 years called Abrisavo.
Job promotes a woman’s immune system during pregnancy and protects infants in the first weeks of her life.
But infants born prematurely before 32 weeks have no time to protect against that vaccine before they are born.
Instead, they will be given disarray.
Unlike a vaccine, which inspires the body to make antibodies and takes a few weeks to be effective, provides immediate protection from Niranvimab RSV infection.
33 -year -old Seri Cox, her son, Harry, wanted to preserve Harry as much as possible against RSV. As a pediatric nurse, he has seen what he can do.
“I know a lot about the virus by working in an entity, where we see a lot of children with RSV every year,” she said.
“It is surprising that this vaccination will now be introduced to young children across the country. I hope we will see at least in our hospital in this winter.”
Harry participated in an international clinical test of vaccination at the University Hospital Southampton.
In England, Scotland, Wales and Northern Ireland, premature children and high -risk babies will benefit from drugs.
What are the symptoms of RSV?
They usually begin within a few days of being infected.
Most people get only cold -like symptoms, such as:
- Picker
- A cough
- Sneeze
- Tiredness
- A high temperature – your back or chest in signals makes normal, sweating and shivering (chills)
Children with RSV can also be irritable and can eat less than normal.
If the RSV leads to a more severe infection (eg pneumonia or broncholitis), it can also happen:
- Axle
- Breathing difficulty
- Rapid breathing or long gaps
- Difficulty in feeding (infants)
- Noise)
- Confusion (in older adults)
Source: NHS UK website